Quantification of the variability in response to propofol administration in children

Klaske van Heusden1, J Mark Ansermino, Kristian Soltesz

  • 1Department of Electrical and Computer Engineering, University of British Columbia, Vancouver, BC V6T 1Z4, Canada. klaskeh@ece.ubc.ca

Insights

This study presents 47 validated models of propofol's effect in children, crucial for developing robust closed-loop anesthesia control systems. These models address interpatient variability, aiming for safer and more efficient anesthesia delivery.

Area of Science:

  • Anesthesiology
  • Pharmacokinetics
  • Control Systems Engineering

Background:

  • Closed-loop anesthesia control promises reduced drug dosage, faster recovery, enhanced patient safety, and decreased anesthesiologist workload.
  • Clinical studies have shown the potential of closed-loop anesthesia, but interpatient variability in drug sensitivity poses a significant challenge for widespread adoption.

Purpose of the Study:

  • To develop reliable models characterizing interpatient variability in anesthetic drug response for robust closed-loop system design.
  • To address system uncertainty that can lead to performance degradation or instability in closed-loop anesthesia.

Main Methods:

  • Model identification from clinical data, focusing on predictive accuracy for closed-loop behavior evaluation.
  • Validation of approximate models for controller design.

Main Results:

  • A set of 47 validated models detailing interpatient variability in propofol response in pediatric patients was developed.
  • The validated models are suitable for robust linear controller design under similar experimental conditions.

Conclusions:

  • Characterizing interpatient variability is essential for developing safe and effective closed-loop anesthesia systems.
  • The presented model set provides a foundation for robust controller design in pediatric propofol anesthesia.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...